BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14751160)

  • 1. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.
    Li AJ; Madden AC; Cass I; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2004 Jan; 92(1):211-4. PubMed ID: 14751160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival.
    Cohen JG; Tran AQ; Rimel BJ; Cass I; Walsh CS; Karlan BY; Li AJ
    Gynecol Oncol; 2014 Mar; 132(3):556-9. PubMed ID: 24423879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
    Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytosis in advanced epithelial ovarian cancer.
    Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
    J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Crasta JA; Premlatha TS; Krishnan SM; Vallikad E; Rameshkumar K
    Indian J Pathol Microbiol; 2010; 53(1):54-6. PubMed ID: 20090223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
    Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
    J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
    Heng S; Benjapibal M
    Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Allensworth SK; Langstraat CL; Martin JR; Lemens MA; McGree ME; Weaver AL; Dowdy SC; Podratz KC; Bakkum-Gamez JN
    Gynecol Oncol; 2013 Sep; 130(3):499-504. PubMed ID: 23747328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.
    Gungor T; Kanat-Pektas M; Sucak A; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Jan; 279(1):53-6. PubMed ID: 18470520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
    Lee M; Kim SW; Nam EJ; Yim GW; Kim S; Kim YT
    Gynecol Oncol; 2011 Aug; 122(2):238-41. PubMed ID: 21531448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor.
    Kuyumcuoglu U; Guzel AI; Celik Y; Erdemoğlu M
    Eur J Gynaecol Oncol; 2010; 31(5):514-6. PubMed ID: 21061791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
    Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
    BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.
    Okunade KS; Dawodu O; Adenekan M; Nwogu CM; Awofeso O; Ugwu AO; Salako O; John-Olabode S; Olowoselu OF; Anorlu RI
    Niger J Clin Pract; 2020 Aug; 23(8):1141-1147. PubMed ID: 32788493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Liu XY
    Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of thrombocytosis in patients with epithelial ovarian cancer.
    Zeimet AG; Marth C; Müller-Holzner E; Daxenbichler G; Dapunt O
    Am J Obstet Gynecol; 1994 Feb; 170(2):549-54. PubMed ID: 8116711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
    Li AJ; Karlan BY
    Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.
    Gorelick C; Andikyan V; Mack M; Lee YC; Abulafia O
    Int J Gynecol Cancer; 2009 Nov; 19(8):1384-9. PubMed ID: 20009894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of thrombocytosis in patients with primary lung cancer.
    Pedersen LM; Milman N
    Eur Respir J; 1996 Sep; 9(9):1826-30. PubMed ID: 8880098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.